Abstract:In the last 50 years, nucleoside analogs have been introduced to drug therapy as antivirals for different types of cancer due to their interference in cellular proliferation. Among the first line of nucleoside treatment drugs, ribavirin (RBV) is a synthetic N-nucleoside with a 1,2,4-triazole moiety that acts as a broad-spectrum antiviral. It is on the World Health Organization (WHO) list of essential medicines. However, this important drug therapy causes several side effects due to its nonspecific mechanism of action. There is thus a need for a continuous study of its scaffold. A particular approach consists of connecting d-ribose to the nitrogen-containing base with a C-C bond. It provides more stability against enzymatic action and a better pharmacologic profile. The coronavirus disease (COVID) pandemic has increased the need for more solutions for the treatment of viral infections. Among these solutions, remdesivir, the first C-nucleoside, has been approved by the Food and Drug Administration (FDA) for clinical use against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It drew attention to the study of the C-nucleoside scaffold. Different C-nucleoside patterns have been synthesized over the years. They show many important activities against viruses and cancer cell lines. 1,2,3-Triazolyl-C-nucleoside derivatives are a prolific and efficient subclass of RBV analogs close to the already-known RBV with a C-C bond modification. These compounds are often prepared by alkynylation of the d-ribose ring followed by azide-alkyne cycloaddition. They are reported to be active against the Crimean-Congo hemorrhagic fever virus and several tumoral cell lines, showing promising biological potential. In this review, we explore such approaches to 1,2,3-triazolyl-C-nucleosides and their evolution over the years.

Synthesis of 1,2,3- Triazole Nucleoside Analogues

Novel triazole nucleoside analogs with anticancer activity

Triazole Nucleoside Derivatives Bearing Aryl Functionalities on the Nucleobases Show Antiviral and Anticancer Activity

Synthesis and Bioactivity of Novel Trisubstituted Triazole Nucleosides.

Synthesis of N-(1-oxyl-2,2,5,5-tetramethylpyrrolin-3-yl)-N '-(mercapto-1,2,4-triazol-4-yl)ureas and N-(3-aryl-5-mercapto-1,2,4-triazol-4-yl)-(1-oxyl-2,2,5,5-tetramethylpyrrolin-3-yl)acidamide

Synthesis and Antitumor Activities of Novel 1,2,3-Triazolefused Oligoconjugates Based on Nucleoside and Saccharide

Synthesis of Nucleoside Analogues with Aromatic Systems Appended on the Triazole Nucleobase

Synthesis and antitumor activity of novel 2',3'-diethanethio-2',3',5'-trideoxy-5'-triazolonucleoside analogues.

Synthesis and Antitumor Activity of 2-Aryl-1, 2, 4-Triazolo[1, 5-A] Pyridine Derivatives

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Synthesis of Some Novel 1,2,3-Triazole-fused Oligonucleoside and Oligosaccharide Analogues

Developments in the chemistry and biology of 1,2,3-triazolyl-C-nucleosides

Synthesis and antitumor activity of novel 2',3'-dideoxy-2',3'-diethanethionucleosides bearing 1,2,3-triazole residues.

Synthesis of Antiviral Acyclic C-nucleosides Incorporating 4-Thiazolinones Structure

Synthesis of Substituted 1,2,4-Triazole-3-Thione Nucleosides Using E. coli Purine Nucleoside Phosphorylase

Synthesis and Anti-Hiv Activity of Triazolo-fused 3′,4′-Cyclic and 4′-Spiro Nucleoside Analogues

Novel Triazole Nucleoside Analogues Promote Anticancer Activity Via Both Apoptosis and Autophagy

A Library of 1,2,3-Triazole-substituted Oleanolic Acid Derivatives As Anticancer Agents: Design, Synthesis, and Biological Evaluation

Novel Aryltriazole Acyclic C-azanucleosides As Anticancer Candidates

ChemInform Abstract: Synthesis and Antitumor Activity of Novel 2′,3′‐Diethanethio‐2′,3′,5′‐trideoxy‐5′‐triazolonucleoside Analogues.

Synthesis of some novel 1, 2, 3-triazole-fused oligonucleoside and oligosaccharide analogues